I 

115TH CONGRESS 

2D SESSION H. R. 5980 

To authorize, develop, and implement a coordinated tracking system of federally-funded initiatives and grant programs for substance abuse treatment, 

prevention, and enforcement, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 25, 2018 

Mr. ROTHFUS introduced the following bill; which was referred to the 

Committee on Oversight and Government Reform 

A BILL 

To authorize, develop, and implement a coordinated tracking 

system of federally-funded initiatives and grant programs 

for substance abuse treatment, prevention, and enforcement, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Coordinated Overdose 

5 and Drug Epidemic Response to the Emergency Declara6 tion Act’’ or the ‘‘CODE RED Act’’. 


dlhill on DSK3GLQ082PROD with BILLS
2 

•HR 5980 IH

1 SEC. 2. AUTHORIZATION, DEVELOPMENT, AND IMPLEMEN2 TATION OF A COORDINATED TRACKING SYS3 TEM. 

4 (a) ESTABLISHMENT.—The Director, shall establish 

5 a coordinated tracking system of federally-funded initia6 tives and grant programs which shall— 

7 (1) be the central repository of all relevant 

8 grants; 

9 (2) identify duplication, overlap, or gaps in 

10 funding to provide increased accountability of feder11 ally-funded grants for substance abuse treatment, 

12 prevention, and enforcement; 

13 (3) identify impediments that applicants cur14 rently have in the grant application process with ap15 plicable agencies; and 

16 (4) be developed and maintained by the Office 

17 with the support of designated National Drug Con18 trol Program Agencies, and any other agency deter19 mined by the Director. 

20 (b) PERFORMANCE METRICS.—The Director shall 

21 identify metrics and achievable goals for grant recipients 

22 in furtherance of the Strategy. Such metrics should be 

23 used to measure how effective each federally-funded initia24 tive is in achieving the objectives of the Strategy and to 

25 enable comparisons of federally-funded initiatives to iden26 tify those that are the most cost effective. 


dlhill on DSK3GLQ082PROD with BILLS
3 

•HR 5980 IH

1 (c) GRANT APPLICATION STANDARDIZATION.—The 

2 Director, in consultation with the head of each National 

3 Drug Control Program Agency, shall develop a plan for 

4 coordinating and standardizing drug control grant appli5 cation processes and develop a joint application to be used 

6 by all National Drug Control Program Agencies to reduce 

7 the administrative burden and improve oversight of Fed8 eral funds. 

9 (d) CENTRAL PORTAL.—The Director shall maintain 

10 on the public, electronic portal of the Office a list all drug 

11 control grant award opportunities available in a central 

12 location. The head of each National Drug Control Pro13 gram Agency shall provide a complete list of all drug con14 trol program grant award opportunities to the Director 

15 and annually update such list. 

16 (e) REPORT TO CONGRESS.—Not later than 180 days 

17 after the date of the enactment of this Act, the Director 

18 shall submit to Congress a report on progress under this 

19 section and the feasibility of block grants of Federal fund20 ing to States. 

21 (f) DEFINITIONS.—In this section: 

22 (1) AGENCY.—The term ‘‘agency’’ has the 

23 meaning given the term ‘‘executive agency’’ in sec24 tion 102 of title 31, United States Code. 


dlhill on DSK3GLQ082PROD with BILLS
4 

•HR 5980 IH

1 (2) DEMAND REDUCTION.—The term ‘‘demand 

2 reduction’’ means any activity conducted by a Na3 tional Drug Control Program Agency, other than an 

4 enforcement activity, that is intended to reduce or 

5 prevent the use of drugs or support or provide treat6 ment and recovery efforts, including— 

7 (A) education about the dangers of illicit 

8 drug use; 

9 (B) services, programs, or strategies to 

10 prevent substance use disorder, including evi11 dence-based education campaigns, community12 based prevention programs, opioid diversion, 

13 collection and disposal of unused prescription 

14 drugs, and services to at-risk populations to 

15 prevent or delay initial use of an illicit sub16 stance; 

17 (C) substance use disorder treatment; 

18 (D) illicit drug use research; 

19 (E) drug-free workplace programs; 

20 (F) drug testing, including the testing of 

21 employees; 

22 (G) interventions for illicit drug use and 

23 dependence; 


dlhill on DSK3GLQ082PROD with BILLS
5 

•HR 5980 IH

1 (H) expanding availability of access to 

2 health care services for the treatment of sub3 stance use disorders; 

4 (I) international drug control coordination 

5 and cooperation with respect to activities de6 scribed in this paragraph; 

7 (J) pre- and post-arrest criminal justice 

8 interventions such as diversion programs, drug 

9 courts, and the provision of evidence-based 

10 treatment to individuals with substance use dis11 orders who are arrested or under some form of 

12 criminal justice supervision, including medica13 tion assisted treatment; 

14 (K) other coordinated and joint initiatives 

15 among Federal, State, local, and Tribal agen16 cies to promote comprehensive drug control 

17 strategies designed to reduce the demand for, 

18 and the availability of, illegal drugs; 

19 (L) international illicit drug use education, 

20 prevention, treatment, recovery, research, reha21 bilitation activities, and interventions for illicit 

22 drug use and dependence; and 

23 (M) research related to any of the activi24 ties described in this paragraph. 


dlhill on DSK3GLQ082PROD with BILLS
6 

•HR 5980 IH

1 (3) DIRECTOR.—The term ‘‘Director’’ means 

2 the Director of the Office of National Drug Control 

3 Policy. 

4 (4) DRUG CONTROL.—The term ‘‘drug control’’ 

5 means any activity conducted by a National Drug 

6 Control Program Agency involving supply reduction 

7 or demand reduction. 

8 (5) ILLICIT DRUG USE; ILLICIT DRUGS; ILLE9 GAL DRUGS.—The terms ‘‘illicit drug use’’, ‘‘illicit 

10 drugs’’, and ‘‘illegal drugs’’ include the illegal or il11 licit use of prescription drugs. 

12 (6) NATIONAL DRUG CONTROL PROGRAM AGEN13 CY.—The term ‘‘National Drug Control Program 

14 Agency’’ means any agency (or bureau, office, inde15 pendent agency, board, division, commission, sub16 division, unit, or other component thereof) that is 

17 responsible for implementing any aspect of the Na18 tional Drug Control Strategy, including any agency 

19 that receives Federal funds to implement any aspect 

20 of the National Drug Control Strategy, but does not 

21 include any agency that receives funds for drug con22 trol activity solely under the National Intelligence 

23 Program or the Military Intelligence Program. 

24 (7) OFFICE.—The term ‘‘Office’’ means the Of25 fice of National Drug Control Policy. 


dlhill on DSK3GLQ082PROD with BILLS
7 

•HR 5980 IH

1 (8) STRATEGY.—The term ‘‘Strategy’’ means 

2 the National Drug Control Program Strategy. 

3 (9) SUPPLY REDUCTION.—The term ‘‘supply 

4 reduction’’ means any activity or program conducted 

5 by a National Drug Control Program Agency that is 

6 intended to reduce the availability or use of illegal 

7 drugs in the United States or abroad, including— 

8 (A) law enforcement outside the United 

9 States; 

10 (B) domestic law enforcement; 

11 (C) source country programs, including 

12 economic development programs primarily in13 tended to reduce the production or trafficking 

14 of illicit drugs; 

15 (D) activities to control international traf16 ficking in, and availability of, illegal drugs, in17 cluding— 

18 (i) accurate assessment and moni19 toring of international drug production and 

20 interdiction programs and policies; and 

21 (ii) coordination and promotion of 

22 compliance with international treaties re23 lating to the production, transportation, or 

24 interdiction of illegal drugs; 


dlhill on DSK3GLQ082PROD with BILLS
8 

•HR 5980 IH

1 (E) activities to conduct and promote 

2 international law enforcement programs and 

3 policies to reduce the supply of drugs; 

4 (F) activities to facilitate and enhance the 

5 sharing of domestic and foreign intelligence in6 formation among National Drug Control Pro7 gram Agencies, relating to the production and 

8 trafficking of drugs in the United States and in 

9 foreign countries; 

10 (G) activities to prevent the diversion of 

11 drugs for their illicit use; and 

12 (H) research related to any of the activi13 ties described in this paragraph. 

Æ 


dlhill on DSK3GLQ082PROD with BILLS